Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)

NCT03792516 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Vulvar Dysplasia
HPV-Related Vulvar Intraepithelial Neoplasia
Preinvasive Vulvar Disease
Vulva Intraepithelial Neoplasia
Vulvar Diseases

Interventions

DRUG: artesunate ointment 40%

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]